Gyre Therapeutics (GYRE) Net Cash Flow Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 198.34% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 467.41% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -14,223.53% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 453.08% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -125.22% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 53.46% |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn | -94.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -94.78% |
| Dec 31, 2025 | 9.58% |
| Sep 30, 2025 | 1,203.26% |
| Jun 30, 2025 | 257.52% |
| Mar 31, 2025 | 186.51% |
| Dec 31, 2024 | -119.05% |
| Sep 30, 2024 | -147.87% |
| Jun 30, 2024 | -93.93% |
| Mar 31, 2024 | 26.34% |
| Dec 31, 2023 | 174.15% |
| Sep 30, 2023 | 101.35% |
| Jun 30, 2023 | -117.30% |
| Mar 31, 2023 | 47.61% |
| Dec 31, 2022 | -81.57% |
| Sep 30, 2022 | -261.62% |
| Jun 30, 2022 | 530.62% |
| Mar 31, 2022 | -118.09% |
| Dec 31, 2021 | -372.39% |
| Sep 30, 2021 | 57.89% |
| Jun 30, 2021 | 15.04% |
| Mar 31, 2021 | -4.20% |
| Dec 31, 2020 | 171.08% |
| Sep 30, 2020 | -711.21% |
| Jun 30, 2020 | -44.49% |
| Mar 31, 2020 | 988.59% |
| Dec 31, 2019 | -59.85% |
| Sep 30, 2019 | 152.72% |
| Jun 30, 2019 | 90.41% |
| Mar 31, 2019 | -105.79% |
| Dec 31, 2018 | -254.16% |
| Sep 30, 2018 | 50.84% |
| Jun 30, 2018 | -827.96% |
| Mar 31, 2018 | 4,439.29% |
| Dec 31, 2017 | 227.77% |
| Sep 30, 2017 | -975.64% |
| Jun 30, 2017 | 216.91% |
| Mar 31, 2017 | 71.07% |
| Dec 31, 2016 | -84.22% |
| Sep 30, 2016 | -109.70% |
| Jun 30, 2016 | -4,067.09% |
| Mar 31, 2016 | -1,722.10% |
| Dec 31, 2015 | 391.40% |
| Sep 30, 2015 | 75.55% |
| Jun 30, 2015 | 114.59% |
| Mar 31, 2015 | 105.56% |
| Dec 31, 2014 | -110.33% |
| Sep 30, 2014 | 997.20% |
| Jun 30, 2014 | 76.12% |
| Mar 31, 2014 | 23.71% |
| Dec 31, 2013 | 393.51% |
| Sep 30, 2013 | -120.13% |
| Jun 30, 2013 | 60.04% |
| Mar 31, 2013 | 33.50% |
| Dec 31, 2012 | 117.36% |
| Sep 30, 2012 | 117.44% |
| Jun 30, 2012 | -158.09% |
| Mar 31, 2012 | 31.10% |
| Dec 31, 2011 | -16.61% |
| Sep 30, 2011 | -4.95% |